DEC-NET Serial number GB277 |
|
Published online | 07/07/2004 13.13.00 |
Last updated | 02/08/2005 14.00.32 |
| |
Other protocol ID number | N0012128260 |
This trial has been approved by an ethics committee |
Current trial status | Open (actively recruiting new participants) |
First subject enrolment Target N. of subjects |
02/2003 N/A |
Major Disease (ICD9 class) | CLEFT PALATE NOS |
Experimental drug |
Codeine Phosphate
Treatment regimen (dosage and duration) N/A |
Gender | Both |
Age (range) | 0 -2 years |
Eligibility criteria |
Inclusion criteria |
Infants with cleft palates undergoing surgical repair |
Exclusion criteria |
Informed consent not given |
Trial design/methodology |
Phase | 4 |
Kind of study | Efficacy Pharmacokinetics |
Design | Controlled Randomised Blinded Double blind
|
Purpose of study |
To determine the efficacy of Codeine Phosphate after cleft palate repair in infants, and to determine how much is metabolised to morphine in this age group |
Primary outcomes |
Reduction in pos-operative pain |
Secondary outcomes |
Metabolism to Morphine |
Summary of study design, objectives, and ongoing research findings |
Double blind randomised study.
Random allocation (A) Codeine phosphate after cleft palate repair (B) No codeine phosphate . |